Zacks Research Downgrades Uranium Royalty (NASDAQ:UROY) to Hold

Uranium Royalty (NASDAQ:UROY) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday, Zacks reports.

Several other equities research analysts have also recently commented on UROY. Weiss Ratings cut Uranium Royalty from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 17th. HC Wainwright reissued a “buy” rating and issued a $4.50 target price on shares of Uranium Royalty in a research report on Thursday, July 16th. Finally, National Bank Financial started coverage on shares of Uranium Royalty in a research note on Wednesday, July 29th. They set an “outperform” rating and a $3.75 target price on the stock. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Uranium Royalty has a consensus rating of “Moderate Buy” and an average target price of $4.12.

Uranium Royalty Trading Up 0.9%

Shares of UROY opened at $4.28 on Monday. The company has a market cap of $1.63 billion, a price-to-earnings ratio of 214.00 and a beta of 1.42. The business’s fifty day simple moving average is $3.73 and its two-hundred day simple moving average is $3.58. Uranium Royalty has a 12 month low of $2.56 and a 12 month high of $5.52.

Uranium Royalty (NASDAQ:UROY) last posted its quarterly earnings results on Monday, September 14th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.05. The firm had revenue of $51.68 million during the quarter, compared to analysts’ expectations of $156.54 million. Uranium Royalty had a return on equity of 18.89% and a net margin of 25.83%. As a group, research analysts forecast that Uranium Royalty will post 0.05 EPS for the current year.

Hedge Funds Weigh In On Uranium Royalty

Several hedge funds and other institutional investors have recently modified their holdings of the company. CenterBook Partners LP grew its holdings in shares of Uranium Royalty by 828.7% in the fourth quarter. CenterBook Partners LP now owns 4,447,408 shares of the company’s stock worth $15,744,000 after acquiring an additional 3,968,521 shares during the period. Banque Cantonale Vaudoise lifted its holdings in Uranium Royalty by 9.7% in the first quarter. Banque Cantonale Vaudoise now owns 272,026 shares of the company’s stock valued at $994,000 after acquiring an additional 24,000 shares during the period. Renaissance Technologies LLC lifted its holdings in Uranium Royalty by 206.5% in the first quarter. Renaissance Technologies LLC now owns 196,751 shares of the company’s stock valued at $718,000 after acquiring an additional 132,551 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in Uranium Royalty by 189.0% in the first quarter. The Manufacturers Life Insurance Company now owns 149,821 shares of the company’s stock valued at $547,000 after acquiring an additional 97,977 shares during the period. Finally, Royal Bank of Canada boosted its position in Uranium Royalty by 10.3% in the first quarter. Royal Bank of Canada now owns 146,282 shares of the company’s stock worth $534,000 after purchasing an additional 13,692 shares during the last quarter. 24.19% of the stock is owned by institutional investors.

Uranium Royalty Company Profile

Uranium Royalty Corp. is a uranium-focused royalty and streaming company. Rather than primarily mining uranium itself, the company seeks exposure to uranium prices and production by acquiring royalties, streams, offtake agreements, debt investments and equity interests related to uranium projects.

The company’s portfolio includes interests in uranium development, exploration and production assets, as well as physical uranium holdings. Its strategy is designed to provide diversified participation in the uranium sector while limiting the direct operating and capital requirements associated with developing and running mines.

Uranium Royalty Corp.